4.44
1.55%
-0.07
Handel nachbörslich:
4.4018
-0.0382
-0.86%
Finanzdaten der Summit Therapeutics Inc-Aktie (SMMT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
32.45%
0.179
|
0.265 | -0.027 | 0.584 | - |
Operating Expenses
|
75.31%
36.39
|
20.76 | 15.77 | 537.74 | 21.43 |
Benefits Costs and Expenses |
70.65%
36.75
|
21.53 | 14.69 | 542.96 | 79.49 |
Costs And Expenses |
75.31%
36.39
|
20.76 | 15.77 | 537.74 | 26.99 |
Operating Income/Loss |
76.70%
-36.21
|
-20.49 | -15.79 | -537.15 | -20.30 |
Nonoperating Income/Loss |
53.99%
-0.357
|
-0.776 | 1.077 | -5.222 | 1.07 |
Income/Loss From Continuing Operations Before Tax |
71.93%
-36.57
|
-21.27 | -14.72 | -542.38 | -79.49 |
Income/Loss From Continuing Operations After Tax |
71.93%
-36.57
|
-21.27 | -14.72 | -542.38 | -19.23 |
Net Income/Loss
|
71.93%
-36.57
|
-21.27 | -14.72 | -542.38 | -19.23 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
96.09%
27.28
|
697.74 | 697.69 | 378.16 | 78.23 |
Diluted Average Shares |
96.09%
27.28
|
697.74 | 697.69 | 378.16 | 78.23 |
Basic Earnings Per Share |
66.67%
-0.01
|
-0.03 | -0.02 | -1.43 | 0.11 |
Diluted Earnings Per Share |
66.67%
-0.01
|
-0.03 | -0.02 | -1.43 | 0.11 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):